resveratrol has been researched along with Retinopathy of Prematurity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, TT; Duan, R; Hu, WH; Leung, KW; Qin, QW; Tsim, KW; Zhang, XY | 1 |
| Kim, WT; Suh, ES | 1 |
2 other study(ies) available for resveratrol and Retinopathy of Prematurity
| Article | Year |
|---|---|
Resveratrol, an Inhibitor Binding to VEGF, Restores the Pathology of Abnormal Angiogenesis in Retinopathy of Prematurity (ROP) in Mice: Application by Intravitreal and Topical Instillation.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Mice; Neovascularization, Pathologic; Resveratrol; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2022 |
Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy.
Topics: Analysis of Variance; Animals; Animals, Newborn; Blotting, Western; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Humans; Infant, Newborn; Nitric Oxide Synthase; Oxygen; Rats; Rats, Sprague-Dawley; Resveratrol; Retina; Retinopathy of Prematurity; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Stilbenes | 2010 |